Hans-Christoph Steinhausen Selected Research

Hans-Christoph Steinhausen Research Topics

Disease

21	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2021 - 12/2006
3	Depressive Disorder (Melancholia) 01/2016 - 12/2006
2	Substance-Related Disorders (Drug Abuse) 01/2021 - 01/2016
2	Mental Disorders (Mental Disorder) 01/2016 - 09/2014
2	Conduct Disorder (Conduct Disorders) 02/2014 - 12/2006
2	Vomiting 01/2009 - 08/2002
2	Bulimia (Binge Eating) 01/2009 - 08/2002
1	Social Phobia 10/2019
1	Agoraphobia 10/2019
1	Seasonal Affective Disorder 10/2019
1	Disorders of Excessive Somnolence (Hypersomnia) 10/2019
1	Specific Phobia 01/2016
1	Anxiety Disorders (Anxiety Disorder) 01/2016
1	Personality Disorders (Personality Disorder) 01/2016
1	Psychotic Disorders (Schizoaffective Disorder) 09/2015
1	Schizophrenia (Dementia Praecox) 09/2015
1	Wounds and Injuries (Trauma) 07/2015
1	Sexual Trauma 07/2015
1	Type 2 Diabetes Mellitus (MODY) 09/2014
1	Weight Gain 09/2014
1	Chromosome Aberrations (Chromosome Abnormalities) 04/2013
1	Neoplasms (Cancer) 04/2013
1	Motor Skills Disorders (Motor Skills Disorder) 03/2012
1	Antisocial Personality Disorder (Antisocial Personality) 12/2011
1	Mutism (Selective Mutism) 01/2010
1	Dyslexia (Alexia) 08/2009
1	Hypoxia (Hypoxemia) 02/2008
1	Epilepsy (Aura) 02/2008
1	Seizures (Absence Seizure) 02/2008
1	Anorexia Nervosa 01/2008
1	Tourette Syndrome (Tourette's Syndrome) 12/2006
1	Tics (Tic) 12/2006
1	Oppositional Defiant Disorder 12/2006
1	Sclerosis 09/2002
1	Fragile X Syndrome (Martin Bell Syndrome) 09/2002
1	Prader-Willi Syndrome (Syndrome, Prader-Willi) 09/2002
1	Fetal Alcohol Spectrum Disorders 09/2002
1	Compulsive Personality Disorder (Obsessive Compulsive Personality) 08/2002

Drug/Important Bio-Agent (IBA)

4	Methylphenidate (Ritalin)FDA LinkGeneric 01/2018 - 04/2013
4	Antipsychotic Agents (Antipsychotics)IBA 09/2015 - 04/2013
3	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2018 - 12/2006
3	Serotonin (5 Hydroxytryptamine)IBA 01/2016 - 10/2008
2	AmphetaminesIBA 01/2018 - 04/2013
2	Dopamine (Intropin)FDA LinkGeneric 01/2016 - 11/2013
2	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2016 - 12/2006
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 08/2014 - 04/2007
2	Antidepressive Agents (Antidepressants)IBA 02/2014 - 04/2013
2	dicarboxydine (DCD)IBA 03/2012 - 12/2006
2	Cathartics (Purgatives)IBA 01/2009 - 08/2002
1	Indicators and Reagents (Reagents)IBA 01/2021
1	3,4-methylenedioxyethamphetamine (MDEA)IBA 10/2019
1	Amphetamine (Amfetamine)FDA LinkGeneric 10/2017
1	Clonidine (ST 155)FDA LinkGeneric 10/2017
1	Bupropion (Wellbutrin)FDA LinkGeneric 10/2017
1	Modafinil (Provigil)FDA Link 10/2017
1	Lisdexamfetamine Dimesylate FDA Link 10/2017
1	Guanfacine (Tenex)FDA LinkGeneric 10/2017
1	Dexmethylphenidate Hydrochloride FDA LinkGeneric 10/2017
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2016
1	N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA 01/2016
1	SolutionsIBA 07/2015
1	Hypoglycemic Agents (Hypoglycemics)IBA 09/2014
1	Dopamine Receptors (Dopamine Receptor)IBA 08/2014
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2013
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 12/2011
1	Soaps (Soap)IBA 12/2011
1	Neurofibromin 2 (Merlin)IBA 07/2010
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 04/2010
1	A 17 (A-17)IBA 01/2010
1	Complement System Proteins (Complement)IBA 08/2009
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2008
1	perflutren (octafluoropropane)FDA Link 02/2008
1	Anticonvulsants (Antiepileptic Drugs)IBA 02/2008
1	3' Untranslated Regions (3' UTR)IBA 04/2007
1	trans-sodium crocetinate (crocetin)IBA 09/2002

Therapy/Procedure

4	Neurofeedback 01/2014 - 07/2007
1	Treatment Delay 01/2021
1	Therapeutics 10/2017
1	Combined Modality Therapy 10/2017
1	Psychology Biofeedback (Biofeedback) 01/2014
1	Drug Prescriptions 04/2013
1	CHOP-B protocol 09/2010
1	Patient Readmission 01/2008